Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Significant is the Anticipated Growth Rate of the Metagenomic Sequencing Market from 2025 to 2034?

In recent times, the metagenomic sequencing market has seen a rapid expansion. The market, which was worth $2.13 billion in 2024, is projected to rise to $2.5 billion in 2025, multiplying at a compound annual growth rate (CAGR) of 17.5%. This impressive growth during the historical period can be linked to several factors, including increased government engagement, a rise in metagenome sequencing research initiatives, wider use of metagenomics in genomics and diagnostic research, the presence of funding for research, and the evolution of Next Generation Sequencing (NGS) data analysis tools.

The anticipated rapid expansion of the metagenomic sequencing market will see it reach a size of $4.71 billion in 2029, with a compound annual growth rate (CAGR) of 17.1%. Factors contributing to this predicted growth during the forecast period include reducing computational costs, an increasing emphasis on the discovery of new beneficial biomolecules, an upswing in the adoption of high-throughput sequencing technologies, a rising demand for personalized medicine and disease diagnosis, and an increase in infectious diseases prevalence. Significant trends for the forecast period encompass innovative advancements in genomic technologies used in metagenomics, an increase in R&D funding, cutting-edge developments in sequencing technology, and the application of big data for NGS data analysis.

How Are the key drivers expanding the growth of the Metagenomic Sequencing Market?

There’s an anticipated expansion in the metagenomic sequencing market, propelled by the rise in infectious diseases. Pathogenic microorganisms, such as bacteria, viruses, parasites, or fungi cause these diseases that can be transmitted, either directly or indirectly, from one person to another. Susceptibility to infectious diseases increases with prevalence of conditions that weaken our immune system like HIV/AIDS, courses of cancer treatments, and autoimmune disorders. The approach of metagenomic sequencing is instrumental in understanding these infectious diseases, shedding light on their diversity, transmission, resistance to antimicrobials, and outbreak tracking. Subsequently, in a report published by the Government of Canada, a Canada-based federal authority, in January 2023, it was indicated that 135 and 159 rabies samples were submitted in October and November 2022 respectively. Further, according to US-based government agency, the Centers for Disease Control and Prevention in March 2023, there was a 5.9% increase in TB cases, from 7,874 cases in 2021 to 8,331 cases in 2022 in the US. Therefore, the rising incidence of infectious diseases influences the growth of the metagenomic sequencing market.

Request Your Free Metagenomic Sequencing Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=16117&type=smp

Who Are the Dominant Players Pushing the Boundaries of the Metagenomic Sequencing Market?

Major companies operating in the metagenomic sequencing market are:

• F. Hoffmann-La Roche Ltd._x000D_

• Thermo Fisher Scientific Inc._x000D_

• Merck Co. & KGaA_x000D_

• Eurofins Scientific SE_x000D_

• PerkinElmer Inc._x000D_

How Are Market Trends Revolutionizing the Metagenomic Sequencing Industry in Recent Times?

Major corporations in the metagenomic sequencing sector are emphasizing the innovation of sequencing services in order to enhance accuracy, throughput, and economic efficiency. Sequencing services encapsulate cutting-edge genetic technologies that allow for the sequencing of longer DNA sequences, offering a more in-depth understanding of genetic structures than traditional short-read processes. For instance, in April 2024, Denmark’s Clinical Microbiomics A/S, a biotechnology firm, initiated superior long-read sequencing services. With components such as 16S, ITS, 18S rRNA, custom gene sequencing, and detailed genomics and metagenomics, these services provide unmatched resolution and quality in microbe analysis. This in turn enables in-depth examination of microbial groups and aids in creating highly precise metagenome-assembled genomes.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Which Segments Play a Crucial Role in the Expansion of the Metagenomic Sequencing Market?

The metagenomic sequencing market covered in this report is segmented –

1) By Product And Service: Reagents And Consumables, Instruments, Sequencing Services, Analysis And Data Interpretation Solutions

2) By Technology: 16S Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing And De Novo Assembly, Metatranscriptomics

3) By Application: Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization, Drug Discovery, Biofuel, Agriculture, Other Applications

Subsegments:

1) By Reagents And Consumables: DNA Or RNA Extraction Kits, Library Preparation Kits, Sequencing Kits, PCR And qPCR Reagents, Other Consumables (Buffers, Probes)

2) By Instruments: Next-Generation Sequencers (NGS), Third-Party Sequencers, Microarrays, Real-Time PCR Instruments

3) By Sequencing Services: Whole Genome Sequencing (WGS), 16S rRNA Sequencing, Shotgun Metagenomic Sequencing, Amplicon Sequencing, Metatranscriptomic Sequencing

4) By Analysis And Data Interpretation Solutions: Bioinformatics Software, Cloud-Based Data Analysis Services, Data Storage Solutions, Custom Analysis Tools, Data Interpretation Platforms

Which Geographic Areas Are Influencing the Growth of the Metagenomic Sequencing Market?

North America was the largest region in the metagenomic sequencing market in 2023. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Core Features That Define the Metagenomic Sequencing Market?

Metagenomic sequencing is a technique used to analyze the genetic material from an entire community of microorganisms found in a specific environment, without the need for culturing individual species. The method involves the extraction of DNA directly from environmental samples, such as soil, water, or the human gut. The extracted DNA is then sequenced using high-throughput sequencing technologies.

Browse Through More Similar Reports By The Business Research Company:

Next Generation Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

Single-Cell Genome Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

Clinical Oncology Next Generation Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: